Psoriatic Arthritis Therapeutics, By Class ( Interleukin Inhibitors, TNF Inhibitors, PDE4 Inhibitors), By Disease (Asymmetric Psoriatic Arthritis, Symmetric Psoriatic Arthritis, Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis, Spondylitis, Arthritis Mutilans), By Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies) and By Region - Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026


 Request Customization  Ask for Discount
 MDHE7CDFFM8B  |    Aug 01, 2019


Psoriatic arthritis is a chronic disorder causing swelling, inflammation, and stiffness of any joint of the body. This disorder is characterized by the scaly, itchy red patches on the skin. The most common symptoms of psoriatic arthritis are tender joints, lower back pain, swollen fingers, toes, stiffness, and pitted nails. Psoriatic arthritis is a non-curable disease, and the medicines are only relief the pain. Psoriatic arthritis therapeutics is necessary for treating and relieving the symptom of arthritis. Pharmaceutical companies are investing huge funds on research and development of new medicines. The factor fueling the global market for psoriatic arthritis therapeutics is the increasing number of patients due to the high prevalence of arthritis. Other factors responsible for the increase in the worldwide market are energetic efficiency of approved drugs, large patient pool, availability of patient assistance programs, increasing awareness campaigns.



The report offers detailed coverage of Psoriatic Arthritis Therapeutics market and industry trends to provide a comprehensive view of the market. The Psoriatic Arthritis Therapeutics research report includes market estimation & forecasting, demand & supply analysis, price trends, company market share of the leading players in Psoriatic Arthritis Therapeutics market. The report splits the market based on various segments. The Psoriatic Arthritis Therapeutics market report also describes the main players and how they are strengthening their position in the market with the latest innovations, strategic acquisitions, partnership and collaboration. It also provides the financial analysis, SWOT analysis, company overview and portfolio analysis of the leading players in the Psoriatic Arthritis Therapeutics market. 

  • AbbVie
  • Amgen
  • Celgene Corporation
  • Janssen Biotech
  • UCB
  • Pfizer
  • Biogen
  • Novartis AG
  • Eli Lilly and Company
  • Bristol-Myers Squibb

Psoriatic Arthritis Therapeutics Segments

The Psoriatic Arthritis Therapeutics market is segmented as below

Segmentation

Class

  • Interleukin Inhibitors
  • TNF Inhibitors
  • PDE4 Inhibitors

Disease

  • Asymmetric Psoriatic Arthritis
  • Symmetric Psoriatic Arthritis
  • Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis
  • Spondylitis
  • Arthritis Mutilans

Channel

  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies

The Psoriatic Arthritis Therapeutics market report brings market data at one point to understand the Psoriatic Arthritis Therapeutics market growth trends, market size, and future scenario of the market. This analysis will help clients to plan their expansion, investment, merger acquisition strategy and bring the improvement. All the data of Psoriatic Arthritis Therapeutics market is demonstrated in such a way that the end-user can leverage the analyzed data. The analysis includes all segment and sub-segment analysis and their scope, growth rate, market opportunities and challenges. 



The qualitative analysis of Psoriatic Arthritis Therapeutics market report includes competitive landscape, key growth, and restraining factors. In addition to this, the PESTEL, Porter's Five, and Value chain analysis enables users to understand how the micro and macro-economic factors have influenced the Psoriatic Arthritis Therapeutics market.  The global analysis of Psoriatic Arthritis Therapeutics market report allows users to understand the competitive factors in the market, which help them to take strategic business decisions for sustainable growth. 

In Psoriatic Arthritis Therapeutics market report the top-down and bottom-up approach has applied to estimate the market value. In the top-down and bottom-up approach, the report considered primary and secondary research. In the primary research, multiple interviews were conducted with CEOs, CFOs, and product managers of the leading players. The interviews also include the subject matter expert, investors, and end-user interviews. Secondary research includes company annual reports, press releases, whitepapers, market players’ association news portal, government portal, and journals. 

Market Density is a one-stop market research, advisory, consulting and, industry analysis reports platform. The reports' library providing business data and intelligence information on thousands of micro as well as high growth markets with global as well as regional coverage. Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for B2B, B2C, and government organizations around the globe. Market Density helps global clients to deal with the business challenges in the competitive world for sustainable growth.

 

  • About Us
    • Why Should you buy this report (sample)
    • How this report delivers? (sample)
    • Key Questions Answered(sample)
  • Chapter 1: Introduction to Psoriatic Arthritis Therapeutics Market
    • Market Definition
    • Market Segmentation
    • Macro Economic Factor Analysis
  • Chapter 2: Executive Summary
  • Chapter 3: Market Factor Analysis
    • Porter’s Five Forces Analysis
    • PESTEL Analysis
    • Value Chain Analysis
    • SWOT Analysis
    • Pricing Analysis
  • Chapter 4: Global Psoriatic Arthritis Therapeutics Market Estimation & Forecast By Class
    • Interleukin Inhibitors
    • TNF Inhibitors
    • PDE4 Inhibitors
  • Chapter 5: Global Psoriatic Arthritis Therapeutics Market Estimation & Forecast By Disease
    • Asymmetric Psoriatic Arthritis
    • Symmetric Psoriatic Arthritis
    • Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis
    • Spondylitis
    • Arthritis Mutilans
  • Chapter 6: Global Psoriatic Arthritis Therapeutics Market Estimation & Forecast By Channel
    • Online Pharmacies
    • Retail Pharmacies
    • Hospital Pharmacies
  • Chapter 7 Global Psoriatic Arthritis Therapeutics Market Estimation & Forecast By Region
    • North America
    • Asia Pacific
    • Europe
    • EMEA
    • Latin America
  • Chapter 8 Competitive Landscape
    • Competition Mapping
    • Company Profiles (Suppliers)
      • AbbVie
      • Amgen
      • Celgene Corporation
      • Janssen Biotech
      • UCB
      • Pfizer
      • Biogen
      • Novartis AG
      • Eli Lilly and Company
      • Bristol-Myers Squibb
  • Chapter 9 Recommendations
  • Chapter 10 Acronyms and Assumptions

Purchase options

Basic Report $ 110.00
Single User $ 4250.00
Corporate User $ 7250.00